Hints and tips:
...The later it is in development, the higher the valuation will be,” said Moore....
...The four pharmaceutical companies that part-funded the project — Amgen, AstraZeneca, GSK and Johnson & Johnson, — received nine months’ exclusive access to the data, which will now be made available to approved...
...Oxford and AstraZeneca did not respond to requests for comment....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Two other local companies have also signed deals to produce Gamaleya’s Sputnik V vaccine later this month....
...John Moore, a virologist at Cornell University, said the key question was whether the populations receiving each vaccine were comparable because local factors such as who is prioritised for each vaccine...
...Adenovirus-based vaccines, such as Gamaleya’s Sputnik V, Oxford-AstraZeneca’s and Johnson & Johnson’s, for example, are limited by how much information they can hold and what the vaccines can be instructed...
...A committee of Indian pharmaceutical and medical experts has recommended the use of Russia’s Sputnik V coronavirus vaccine to alleviate pressure on the country’s limited supplies as it faces a second wave...
...So called “real-world” analysis of 14,019 cases of the Delta variant in the UK, released by Public Health England in June, found the BioNTech/Pfizer and Oxford/AstraZeneca vaccines were, respectively, 96...
...Most Indians have received Covishield, the Oxford/AstraZeneca shot manufactured by the Serum Institute of India, the world’s largest vaccine maker....
...The Oxford/AstraZeneca jab is also being deployed....
...Melissa Moore, a chief scientific officer at Moderna, has acknowledged this. It is plausible that we will come to regard the current doses as needlessly high....
...The AstraZeneca and J&J shots are both adenoviral vector vaccines — as are Russia’s Sputnik V jab and the shot developed by China’s CanSino Biologics — meaning they use an adenovirus, such as the common...
...SK Bioscience is contracted to produce AstraZeneca jabs for both domestic use and export....
...The Russian Direct Investment Fund, the sovereign wealth fund managing overseas sales and production of Sputnik V, has deals with at least five Indian pharmaceutical companies to produce a combined 850m...
...Several companies in India, a global pharmaceuticals hub, have signed on to manufacture Sputnik V....
...The move was intended to make up for delays in its existing vaccination programme, which is based mostly around Oxford/AstraZeneca vaccines being produced by local pharmaceutical company Siam Bioscience...
...Despite the delays, however, Mr Pazuello has predicted Brazil will “very soon” be exporting vaccines given the country’s pharmaceutical manufacturing capabilities....
...The African Union will pay three times more for Russia’s Sputnik V jab than it is paying for the Oxford/AstraZeneca and Novavax vaccines, according to people familiar with the procurement process....
...“The bulk of the vaccines I think will come from other sources” such as Oxford/AstraZeneca and Russia’s Sputnik V, said one Pakistani official....
...Sputnik V has been approved by 45 foreign countries and is being pitched by Moscow as an alternative to western vaccines produced by multinational pharmaceutical companies....
...However, local manufacturers that have partnered with Sputnik V say they are months away from distributing it domestically....
...New Delhi has yet to give approval for other vaccines, including Russia’s Sputnik V, which has tie-ups with multiple Indian manufacturers to produce millions of doses....
...It comes a day after Indian regulators approved the use of Russia’s Sputnik V jab....
International Edition